Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Lymphangioleiomyomatosis
NCT00989742Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Jul 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxycycline in lymphangioleiomyomatosis (LAM), sponsored by University of Nottingham. Started Jul 2009; status: completed.
02
Drugs
doxycycline
03
Conditions
lymphangioleiomyomatosis (LAM)
Beyond the preview
Go deeper on NCT00989742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989742.